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ABSTRACT
OBJECTIVE: To estimate the relation between catastrophic health expenditure (CHE) and 
multimorbidity in a national representative sample of the Brazilian population aged 50 year 
or older.
METHODS: This study used data from 8,347 participants of the Estudo Longitudinal de Saúde 
dos Idosos Brasileiros (ELSI – Brazilian Longitudinal Study of Aging) conducted in 2015–2016. 
The dependent variable was CHE, defined by the ratio between the health expenses of the adult 
aged 50 years or older and the household income. The variable of interest was multimorbidity 
(two or more chronic diseases) and the variable used for stratification was the wealth score. 
The main analyses were based on multivariate logistic regression.
RESULTS: The prevalence of CHE was 17.9% and 7.5%, for expenditures corresponding to 
10 and 25% of the household income, respectively. The prevalence of multimorbidity was 
63.2%. Multimorbidity showed positive and independent associations with CHE (OR = 1.95, 
95%CI 1.67–2.28, and OR = 1.40, 95%CI 1.11–1.76 for expenditures corresponding to 10% and 
25%, respectively). Expenditures associated with multimorbidity were higher among those 
with lower wealth scores.
CONCLUSIONS: The results draw attention to the need for an integrated approach of 
multimorbidity in health services, in order to avoid CHE, particularly among older adults with 
worse socioeconomic conditions.
DESCRIPTORS: Middle Aged.  Aged.  Multimorbidity.  Socioeconomic Factors. Cost of 
Illness. Catastrophic Expenditure. 
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INTRODUCTION
In recent decades, the concern related to health expenditures has been highlighted 
globally, considering that such expenditures have grown faster than the Gross Domestic 
Product (GDP) of most countries, especially in those with low and middle income1. 
However, higher national expenditure does not necessarily imply better health conditions 
or greater equity in access to services2. In general, health systems should allow people to 
use the services without incurring financial sacrifice, which is part of the goal of universal 
health coverage, proposed by the United Nations in their Sustainable Development Goals3. 
Although many countries are making efforts in this direction, recent data point to an 
increasing trend of catastrophic health expenditures4, those that exceed a percentage 
of the family’s income, consumption or ability to pay3-5. There are different cutoff points, 
varying from 10 to 40%, to define this type of expenditure, depending on the denominator 
used for this calculation3–5.
Data reported by the World Health Organization (WHO) showed that, in 2010, 808 million 
people (11.7% of the world population) incurred health expenditures that exceeded 10% of 
the family budget and, for 179 million people (2.6% of the world population), corresponding 
expenditures exceeded the 25% limit of the family budget3. In Brazil, between 2007 and 
2015, 25.6% of the population incurred health expenditures greater than 10% of the total 
household expenses or income6.
Studies indicate greater impact of catastrophic health expenditures in families with 
lower socioeconomic level7,8. In addition, evidence shows positive association between 
chronic diseases and  greater out-of-pocket health expenditures9,10. Within the 
context of population aging, characterized by the predominance and high burden of 
non-communicable chronic diseases11, the concern about the financial impact generated 
by them has been a studied object9,12.
The phenomenon of multimorbidity — the simultaneous occurrence of more than one 
disease in the same individual13 — is also increasingly common, and with a growing trend14. 
Older adults with multimorbidity represent a complex demand, since they use health 
services more frequently12, raise the costs for health systems12,15 and increase the chances 
of catastrophic expenditures for the families9.
The relation between socioeconomic conditions, chronic diseases and health expenditures 
in the general population has already been evaluated by different studies7-10. However, the 
association between catastrophic health expenditure in older adults is still little explored, 
especially in developing countries. In Brazil, this association is unknown, although 
particularly relevant, considering the fast population aging and the social inequalities in 
health conditions and in the use of services by this population16. Thus, the objectives of this 
study are: (1) to describe the distribution of catastrophic health expenditures (CHE) in a 
national representative sample of the Brazilian population of older adults; (2) to estimate the 
association of these expenditures with multimorbidity; and (3) to assess if the socioeconomic 
conditions interfere in this association.
METHODS
The data used were from the baseline of the Estudo Longitudinal de Saúde dos Idosos 
Brasileiros (ELSI – Brazilian Longitudinal Study of Aging), conducted in 2015 and 2016 in a 
sample representative of the non-institutionalized Brazilian population, aged 50 years or 
older. The ELSI-Brasil used a probabilistic sample selected by stratification processes and 
conglomerates, in different stages. In the selected households, all residents 50 years or older 
were eligible for the interview and other procedures. The final sample of the ELSI-Brasil 
baseline was composed of 9.412 individuals, residing in 70 municipalities in different regions 
of the country. 
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In this study, all individuals aged 50 years or older who participated in the baseline survey 
of the research and who had all the necessary information for the proposed data analysis 
were considered, totaling 8.347 people. More details on the ELSI-Brasil may be seen on the 
investigation homepage (elsi.cpqrr.fiocruz.br) and in a previous publication17.
The ELSI-Brasil was approved by the Research Ethics Committee of the René Rachou 
Institute of the Oswaldo Cruz Foundation (CAAE:34649814.3.0000.5091) and all participants 
signed the informed consent form before the interviews.
Dependent Variable
The dependent variable of the study was catastrophic health expenditure (yes/no), defined 
as the ratio between  out-of-pocket expenditure, relative to all health expenditure incurred 
by the adults aged 50 years or older in the last 30 days, and the total household income. 
Individuals whose expenditures reached values equal or greater than 10% or values equal 
or greater than 25% of the household income were classified as incurring catastrophic 
expenditures, as previously proposed3,4.
The following health expenditures were considered to compose the out-of-pocket 
expenditure: medical consultation, dentist consultation, hospitalizations, physiotherapist, 
occupational therapist, speech therapist, psychologist, caregiver/nursing technician, 
laboratory/image and other examinations, nutritionist and medications. The ELSI-Brasil 
considered the recall period of 90 days for health expenditure, except for drug expenses, 
collected based on the last 30 days. Thus, to allow the sum of the values and to calculate 
the out-of-pocket expenditure in the last 30 days, the expenses evaluated with recall period 
of 90 days were divided by three. All the variables related to spending and income were 
deflated for the year of 2015, using the Índice Nacional de Preços ao Consumidor Amplo 
(IPCA – National Broad Consumer Price Index) provided by the Brazilian Institute of 
Geography and Statistics (IBGE). The purchasing power of 1 real equated, on average, to 
95 cents in 2015.
Household income was established by the sum of the incomes of all residents, considering 
five sources: salary or self-employment; retirement or death pension; Bolsa Família (Family 
Allowance Program), Benefício de Prestação Continuada (Continued Installment Benefit 
Program), alimony or cash donation; rents or leases; and others. The missing data for one 
or more items represented absence of income in the item in question. Respondents who did 
not report the exact value of income were asked to inform the closest interval, using the 
midpoint of the interval as income value. For the last class interval, the value was imputed 
considering the median gain of the other residents with income in this range, who informed 
their income in the open question.
Covariates
Multimorbidity, defined as the presence of two or more chronic health conditions13, was 
the main independent variable. Chronic diseases were selected from a list with 17 diseases, 
including: high blood pressure, diabetes, high cholesterol, heart attack, angina, heart 
failure, stroke, asthma, chronic obstructive pulmonary disease, arthritis or rheumatism, 
osteoporosis, spine problem, depression, cancer, chronic kidney failure, Parkinson’s disease 
and Alzheimer’s disease. The presence of these diseases was evaluated through self-report, 
using the question “Has any doctor ever said you have...”.
Other dependent variables included: age (50–59, 60–69, 70–79 and 80 years or 
older); sex (female and male); proportion of older adults in the household; education 
(no study, 1–3, 4–7 and 8 or more years of study); marital status (with or without 
marital relationship); wealth score (1st, 2nd, 3rd, 4th and 5th quintiles); average 
number of drugs used; private health insurance (yes or no); and functional limitations 
(yes and no).
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The wealth score, categorized in quintiles, was defined by analyzing main components18, 
using information on family ownership of durable goods and housing characteristics: 
household goods (internet, television, cable television, refrigerator, washing machine, 
dishwasher, dryer, computer, desk phone, cell phone, microwave, motorcycle, car) 
and domestic characteristics (maid, masonry or wooden wall, piped water, paved 
street, bathroom).
Functional limitation was evaluated according to the report of difficulties to perform one 
of more basic activities of daily living (crossing from one room to another, getting dressed, 
bathing, eating, lying down and/or getting out of bed and using the toilet).
Data Analysis
A descriptive analysis of the study variables and of the proportion of health expenditures 
in relation to out-of-pocket was performed. Univariate logistic regression was used, 
followed by multiple logistic regression, to assess the association between catastrophic 
Table 1. Sociodemographic and health characteristics of the research participants (Brazilian Longitudinal 











No marital relationship 36.8 33.9–39.8
With marital relationship 63.2 60.2–66.1
Education
No study 12.3 10.0–14.9
1–3 years 18.7 17.1–20.4
4–7 years 31.6 29.1–34.2
8+ years 37.4 34.6–40.4












10% cutoff point 17.9 16.4–19.5
25% cutoff point 7.5 6.6–8.4
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expenditure and each independent variable. The multiple model included all the variables 
with p-value less than 0.20, and those significantly associated with the outcome remained 
in the final model. Results were expressed by odds ratio and respective confidence intervals 
(95%CI). The adjusted probabilities of catastrophic expenditure among individuals 
with multimorbidity according to the wealth score were calculated from including the 
interaction term between multimorbidity and wealth score. Data analysis was performed 
with the Stata 14.0 software (StataCorp College Station, United States), considering sample 
parameters and weights of the individuals.
RESULTS
Table 1 shows the descriptive analysis of the sample, composed mostly of women (54%), 
adults in the age group between 50 and 59 years (46.9%), with marital relationship (63.2%) 
and 8 years or more of study (37.4%). Most of the studied population had multimorbidity 
(63.2%), no functional limitation (84.4%) and no private health insurance (74.1%). The 
prevalence of CHE was 17.9% for the 10% cutoff point of and 7.5% for the 25% cutoff point 
of household income.
The evaluation of components of health expenditure pointed that spending with medications 
represented the greatest proportion of out-of-pocket expenditure (65.1%), followed by 
spending on dentists and with medical consultations (Table 2). 
In the univariate analysis, all variables were significantly associated with catastrophic 
expenditure in both cutoff points, except for education for both points and physical activity 
for the 25% cutoff point of household income (Table 3).
Table 4 shows the results of the factors associated with CHE. After adjusting the model, older 
females, with lower education, functional limitation and who had private health insurance 
were more likely to incur CHE, for both cutoff points. Only the association between 4-7 
years of education and expenditure equal or greater than 25% of household income and the 
association between wealth score for the same cutoff point were not statistically significant 
after adjusting the model. The presence of multimorbidity increased in 95% the chance of 
CHE equal or greater than 10%, in addition to increasing by 40% the chance of CHE equal 
or greater than 25% of household income. The results also pointed out that older adults 
belonging to the highest wealth score are 5% less likely to incur catastrophic expenditure 
for the 10% cutoff point of household income (Table 4).
Table 2. Mean proportion of health expenditures in relation to  out-of-pocket of older adults in Brazil 













Occupational therapist 0.0 0.0–0.07
Speech therapist 0.0 0.0–0.1
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Table 3. Univariate analysis between catastrophic expenditure and independent variables (Brazilian 








Male 0.59 (0.51-0.70)b 0.53 (0.42–0.68)b
Age (years) 1.03 (1.02–1.04)b 1.02 (1.01–1.04)b
Marital status (ref. no)
Yes 0.73 (0.64-0.82)b 0.59 (0.51-0.70)b
Years of study 0.99 (0.98–1.01) 1.00 (0.98–1.02)
Wealth score (ref.a: 1st quintile)
2nd quintile 1.28 (1.02–1.60)c 1.36 (1.03–1.79)c
3rd quintile 1.16 (0.93–1.43) 1.09 (0.81–1.46)
4th quintile 0.94 (0.72–1.23) 0.89 (0.63–1.24)
5th quintile (richest) 0.92 (0.69–1.23) 1.04 (0.72–1.49)
Proportion of older adults in the household 1.01 (1.01–1.01)b 1.01 (1.00–1.01)b
Physical activity (ref.a: no)
Yes 0.79 (0.67-0.93)d 0.84 (0.68–1.04)
Multimorbidity (ref.a: no)
Yes 2.45 (2.11–2.84)b 1.83 (1.47–2.28)b
No. of medications 1.34 (1.30–1.39)b 1.27 (1.22–1.32)b
Functional limitation (ref.a: no)
Yes 2.45 (2.15–2.78)b 2.26 (1.78–2.87)b
Private health insurance (ref.a: no)
Yes 1.36 (1.15–1.60)b 1.49 (1.17–1.88)b
ref.a: reference category
b p < 0.001
c p < 0.05 
d p < 0.01
Table 4. Multiple logistic regression model for factors associated with catastrophic health expenditure 








Male 0.69 (0.58–0.81)a 0.59 (0.45–0.76)a
Age 1.02 (1.01–1.03)a 1.01 (1.01–1.01)b
Education (8+ years)
Did not study 0.65 (0.50–0.85)b 0.64 (0.45–0.91)c
1–3 years 0.71 (0.57–0.89)b 0.75 (0.59–0.96)c
4–7 years 0.79 (0.67–0.93)d 0.82 (0.65–1.04)
Wealth score 0.95 (0.92–0.98)b 0.96 (0.90–1.01)
Proportion of older adults in the household 1.01 (1.00–1.01)a 1.01 (1.00–1.01)b
Multimorbidity
Yes 1.95 (1.67–2.28)a 1.40 (1.11–1.76)b
Functional limitation
Yes 2.06 (1.79–2.37)a 2.04 (1.62–2.56)a
Private health insurance
Yes 1.28 (1.07–1.53)b 1.40 (1.11–1.76)b
a p < 0.001
b p < 0.01
c p < 0.05
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Figure 1 shows the adjusted probabilities of CHE according to the presence of multimorbidity 
and wealth score. In the two cutoff points, there were significant differences between the 
probability of catastrophic expenditures according to the presence of multimorbidity and 
wealth score. CHE probabilities were higher among individuals with multimorbidity and 
lower wealth scores, for both cutoff points.
DISCUSSION
This study verified a significant impact of health expenses on the household income of 
older adults. Approximately one fifth of the individuals analyzed incurred CHE exceeding 
10% of the household income, and 8% of the individuals incurred CHE when the 25% 
cutoff point was used. Spending with medication was the main health expenditure. CHE 
was significantly associated with multimorbidity, which also potentialized the effects of 
socioeconomic inequalities, regardless of the cutoff point used.
The estimated prevalence of CHE for both cutoff points is higher than that found in the 
total population of wealthy countries and Latin American and Caribbean countries4, 
where the estimated CHE reached 13.4% in 2000, considering the total expenditure 
on family health for the cutoff point of 10% of family consumption4. Among wealthy 
countries, a study performed with Australians aged 55 years or older verified that 11.8% 
and 5.1% incurred CHE for the 10% and 25% cutoff points, respectively9. Given the WHO 
Figure. Adjusted probability of catastrophic health expenditure among older adults with and without multimorbidity according to the wealth 
score (Brazilian Longitudinal Study of Aging), 2015–2016. (a) Adjusted probabilities of catastrophic expenditure among older adults with and 
without multimorbidity according to wealth score for each cutoff point. (b) Differences between the probabilities of catastrophic expenditure 
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estimate of 25.6%, between 2007 and 2015, which considered the Brazilian population 
as a whole6, the prevalence of CHE in older adults in the country for the 10% cutoff point 
may be considered high.
The higher prevalence of CHE among older adults, in relation to the total population, has 
been described in literature19, and may be explained by the differences in types and frequency 
of spending among young families, when compared to older adult families. In general, most 
health expenditure relates to spending with medications and medical consultations20. 
Among older adults, in addition to those expenses being higher, their proportion in relation 
to income is also greater15.
Corroborating a previous study9, it was found that individuals with multimorbidity were 
more likely to have catastrophic expenses, regardless of the cutoff point. McRae et al.9 not 
only observed positive association between multimorbidity and CHE among older adults, 
but also verified a gradient in this relation: each additional chronic disease increased in 46% 
the chance of health spending exceeding 20% of the income9. Among the reasons for this 
association, we can mention the greater use of services by individuals with multimorbidity12, 
which is related to the complexity of care, such as the need to use several medications21. 
Individuals with multimorbidity may spend, on average, 10 times more on health than 
those without it10.
Our results also showed that socioeconomic inequality is related to CHE, a relation 
consistently described in literature8,22. In Brazil, the occurrence of CHE for total population 
was 5.2 times higher among the poorest, according to the National Economic Index, and 4.2 
times higher among individuals with less schooling, considering complete years of study8. 
This study advances by showing that the inequalities associated with CHE in older adults 
show distinct patterns, when evaluated as a function of multimorbidity, which potentializes 
the effects of these inequalities. Regardless of the cutoff point used, the probability of CHE 
was greater among individuals with multimorbidity and belonging to the lowest wealth 
scores, when compared to individuals without multimorbidity, and this difference was 
significantly attenuated with increased socioeconomic status.
Both results reinforce the importance of investing in achieving universal health coverage 
that ensures the access to quality care and services, without catastrophically compromising 
the family budget3. In Brazil, the maintenance of the Unified Health System (SUS) is essential 
for this goal to be achieved, since, throughout its 30 years of existence, the system was 
effective in reducing inequalities in the health access and conditions of the population23, 
especially among individuals with chronic diseases, considering that more than 70% of 
Brazilian older adults depend exclusively on SUS24. In addition, data from the most recent 
national survey on access to medications in Brazil showed that 67.7% of Brazilian adults 
and older adults with chronic diseases who had total access to treatment, obtained some 
medications, and 47.5% obtained all their medications, free of charge25.
Although access to free medicines in the SUS is greater among low-income individuals, 
middle-income people also often access public pharmaceutical assistance26. This may be 
related to the type of private health insurance acquired by this portion of the population. 
These insurances commonly have limited coverage for medications, home care, physiotherapy 
and other services, causing individuals who have this type of private health insurance to 
resort to the public system to ensure access to these services27. A recent study demonstrated 
the exclusive use of SUS to obtain medications by 29.3% of the individuals with chronic 
diseases who had a private health insurance, and among 34.4% of those with these diseases 
who belonged to the highest economic classification27. This may be one of the explanations 
for the fact that private health insurance does not constitute a factor of protection against 
catastrophic health expenditures7, and may even increase the occurrence of this outcome, as 
the results of this study indicated. As in Brazil, other recent studies conducted in countries 
such as Mexico28 and China29 have shown that public health programs decrease the risk of 
catastrophic expenditure.
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Among the strengths of this study, we highlight the use of a measure of health expenditure 
composed by a comprehensive number of expenses, usually unavailable in population 
studies, enabling a more specific analysis of spending by older adults in Brazil. However, 
the self-report of chronic diseases may interfere with the estimation of multimorbidity, 
although this measure is considered valid in epidemiological studies, without the occurrence 
of socioeconomic bias30. The fact that this study used out-of-pocket expenditure in the 
numerator, as well as household income in the denominator, to the detriment of total 
health expenditure and the family’s ability to pay, may have reduced the percentage of CHE. 
Although such measures are widely used in research, literature shows no consensus on the 
best form of calculation. The cross-sectional design is another limitation of this study, as it 
prevents the analysis of temporal relationships between the variables. The recall period of 
the measures used to calculate the CHE, restricted to 30 to 90 days, may also have interfered 
with the magnitude of the outcome.
The results of this study help to understand catastrophic health expenditure among 
older adults in Brazil, which can be potentialized by the presence of multimorbidity 
and among individuals with low socioeconomic status. Considering population aging, 
along with an increased prevalence of multimorbidity14, health systems need to adapt 
to this demand, ensuring the access and quality of their services, especially to the less 
advantaged population groups. Future research is necessary to monitor our findings and 
to investigate the influence of specific combinations of diseases on CHE occurrence, in 
order to contribute to the evaluation of the impact of universal health coverage policies 
on reducing inequalities.
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